NCT00871455View on ClinicalTrials.gov

Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2011

Conditions

Spinal Cord Injury

Interventions

DRUG

Baclofen

Subjects will receive 20 mg baclofen for 8 weeks, followed by 40 mg baclofen for 8 weeks.

Trial Locations (1)

10468

VA Medical Center, Bronx, The Bronx

Sponsors

Collaborators (1)

Kessler Foundation

All Listed Sponsors

collaborator

Kessler Foundation

OTHER

lead

US Department of Veterans Affairs

FED

NCT00871455 - Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study | Biotech Hunter | Biotech Hunter